Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

adimolol

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The dual acting α, β-blockers have an important place in the management of hypertension. Molecular dynamics simulations have been… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2004
2004
SummaryMEN 935 [1-(3-((3-(1-naphthoxy)-2-hydroxypropyl)amino)-3,3-dimethylpropyl)-2-benzimidazolinone-hydrochloride monohydrate… 
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
1989
1989
  • R. Palluk, W. Hoefke
  • Archives internationales de pharmacodynamie et de…
  • 1989
  • Corpus ID: 30314308
Adimolol is a new antihypertensive agent with strong nonselective beta- and moderate alpha-adrenolytic properties. In order to… 
1988
1988
It is not surprising that there has been a search for compounds that combine two useful antihypertensive properties. The… 
1987
1987
The central adrenergic blocking activity of adimolol (ADL) was studied in rats and mice in the tests which can differentiate beta… 
1987
1987
A comparative study in eight healthy normotensive males of the effects on blood pressure, heart rate and beta-adrenoceptor… 
1985
1985
The cardiovascular effects of adimolol, a new, potent, long acting beta-adrenoceptor blocking drug were investigated in three… 
  • table 1
  • table 2
  • table 3
  • figure 1
1985
1985
The pharmacokinetic properties of adimolol (MEN 935), a new antihypertensive agents with predominantly beta-receptor blocking and…